MYD88 and cancer: For example, in the context of inflammation-induced cancer, we found that the activated form of MYD88, a regulator of inflammatory signalling, promoted CSC generation in p53−/− MEFs through activation of the NF-κB-HIF1-OCT4, but not the SOX2, induction pathway71.